Literature DB >> 22167188

Endogenous vascular endothelial growth factor-A (VEGF-A) maintains endothelial cell homeostasis by regulating VEGF receptor-2 transcription.

Guangqi E1, Ying Cao, Santanu Bhattacharya, Shamit Dutta, Enfeng Wang, Debabrata Mukhopadhyay.   

Abstract

Vascular endothelial growth factor A (VEGF-A) is one of the most important factors controlling angiogenesis. Although the functions of exogenous VEGF-A have been widely studied, the roles of endogenous VEGF-A remain unclear. Here we focused on the mechanistic functions of endogenous VEGF-A in endothelial cells. We found that it is complexed with VEGF receptor 2 (VEGFR-2) and maintains a basal expression level for VEGFR-2 and its downstream signaling activation. Endogenous VEGF-A also controls expression of key endothelial specific genes including VEGFR-2, Tie-2, and vascular endothelial cadherin. Of importance, endogenous VEGF-A differs from exogenous VEGF-A by regulating VEGFR-2 transcription through mediation of FoxC2 binding to the FOX:ETS motif, and the complex formed by endogenous VEGF-A with VEGFR-2 is localized within the EEA1 (early endosome antigen 1) endosomal compartment. Taken together, our results emphasize the importance of endogenous VEGF-A in endothelial cells by regulating key vascular proteins and maintaining the endothelial homeostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22167188      PMCID: PMC3270960          DOI: 10.1074/jbc.M111.293985

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells.

Authors:  H Abedi; I Zachary
Journal:  J Biol Chem       Date:  1997-06-13       Impact factor: 5.157

2.  Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal.

Authors:  L E Benjamin; E Keshet
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

3.  Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells.

Authors:  Y Watanabe; S W Lee; M Detmar; I Ajioka; H F Dvorak
Journal:  Oncogene       Date:  1997-05-01       Impact factor: 9.867

4.  IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis.

Authors:  Minako Yamaoka-Tojo; Taiki Tojo; Ha Won Kim; Lula Hilenski; Nikolay A Patrushev; Lynn Zhang; Tohru Fukai; Masuko Ushio-Fukai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-06-08       Impact factor: 8.311

5.  Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor.

Authors:  C Patterson; M A Perrella; C M Hsieh; M Yoshizumi; M E Lee; E Haber
Journal:  J Biol Chem       Date:  1995-09-29       Impact factor: 5.157

6.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

Authors:  D R Senger; S J Galli; A M Dvorak; C A Perruzzi; V S Harvey; H F Dvorak
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

7.  Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation.

Authors:  D Guo; Q Jia; H Y Song; R S Warren; D B Donner
Journal:  J Biol Chem       Date:  1995-03-24       Impact factor: 5.157

8.  Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells.

Authors:  Cristina Rabascio; Elisabetta Muratori; Patrizia Mancuso; Angelica Calleri; Valentina Raia; Thomas Foutz; Saverio Cinieri; Giulia Veronesi; Giancarlo Pruneri; Pietro Lampertico; Massimo Iavarone; Giovanni Martinelli; Aron Goldhirsch; Francesco Bertolini
Journal:  Cancer Res       Date:  2004-06-15       Impact factor: 12.701

9.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.

Authors:  P Carmeliet; V Ferreira; G Breier; S Pollefeyt; L Kieckens; M Gertsenstein; M Fahrig; A Vandenhoeck; K Harpal; C Eberhardt; C Declercq; J Pawling; L Moons; D Collen; W Risau; A Nagy
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

10.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.

Authors:  N Ferrara; K Carver-Moore; H Chen; M Dowd; L Lu; K S O'Shea; L Powell-Braxton; K J Hillan; M W Moore
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

View more
  17 in total

1.  VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression.

Authors:  Ying Cao; Guangqi E; Enfeng Wang; Krishnendu Pal; Shamit K Dutta; Dafna Bar-Sagi; Debabrata Mukhopadhyay
Journal:  Cancer Res       Date:  2012-06-12       Impact factor: 12.701

2.  Early VEGFR2 activation in response to flow is VEGF-dependent and mediated by MMP activity.

Authors:  Nathaniel G dela Paz; Benoît Melchior; John A Frangos
Journal:  Biochem Biophys Res Commun       Date:  2013-04-10       Impact factor: 3.575

3.  T11TS impedes glioma angiogenesis by inhibiting VEGF signaling and pro-survival PI3K/Akt/eNOS pathway with concomitant upregulation of PTEN in brain endothelial cells.

Authors:  Debanjan Bhattacharya; Manoj Kumar Singh; Suhnrita Chaudhuri; Sagar Acharya; Anjan Kumar Basu; Swapna Chaudhuri
Journal:  J Neurooncol       Date:  2013-03-08       Impact factor: 4.130

4.  Laminar flow activation of ERK5 protein in vascular endothelium leads to atheroprotective effect via NF-E2-related factor 2 (Nrf2) activation.

Authors:  Miso Kim; Suji Kim; Jae Hyang Lim; ChuHee Lee; Hyoung Chul Choi; Chang-Hoon Woo
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

5.  Protein kinase D up-regulates transcription of VEGF receptor-2 in endothelial cells by suppressing nuclear localization of the transcription factor AP2β.

Authors:  Ying Wang; Luke H Hoeppner; Ramcharan Singh Angom; Enfeng Wang; Shamit Dutta; Heike R Doeppler; Fei Wang; Tao Shen; Isobel A Scarisbrick; Sushovan Guha; Peter Storz; Resham Bhattacharya; Debabrata Mukhopadhyay
Journal:  J Biol Chem       Date:  2019-09-06       Impact factor: 5.157

6.  Up-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinoma.

Authors:  Ju-Bo Zhang; Hui-Chuan Sun; Wei-Dong Jia; Peng-Yuan Zhuang; Yong-Bing Qian; Xiao-Dong Zhu; Ling-Qun Kong; Lu Wang; Wei-Zhong Wu; Zhao-You Tang
Journal:  BMC Cancer       Date:  2012-10-01       Impact factor: 4.430

7.  MicroRNA-107 contributes to post-stroke angiogenesis by targeting Dicer-1.

Authors:  Yanan Li; Ling Mao; Yuan Gao; Suraj Baral; Yifan Zhou; Bo Hu
Journal:  Sci Rep       Date:  2015-08-21       Impact factor: 4.379

8.  Stat3 orchestrates interaction between endothelial and tumor cells and inhibition of Stat3 suppresses brain metastasis of breast cancer cells.

Authors:  Hsueh-Te Lee; Jianfei Xue; Ping-Chieh Chou; Aidong Zhou; Phillip Yang; Charles A Conrad; Kenneth D Aldape; Waldemar Priebe; Cam Patterson; Raymond Sawaya; Keping Xie; Suyun Huang
Journal:  Oncotarget       Date:  2015-04-30

9.  Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes.

Authors:  Ingeborg Klaassen; Ewout W de Vries; Ilse M C Vogels; Antoine H C van Kampen; Machteld I Bosscha; David H W Steel; Cornelis J F Van Noorden; Sarit Y Lesnik-Oberstein; Reinier O Schlingemann
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

10.  Elevated Levels of the Endothelial Molecules ICAM-1, VEGF-A, and VEGFR2 in Microscopic Asymptomatic Malaria.

Authors:  Augustina Frimpong; Jones Amponsah; Dorothy Agyemang; Abigail Sena Adjokatseh; Sophia Eyiah-Ampah; Nana Aba Ennuson; Dorotheah Obiri; Linda Eva Amoah; Kwadwo Asamoah Kusi
Journal:  Open Forum Infect Dis       Date:  2021-06-04       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.